Abstract: A first transmitter transmits a transfer request requesting transfer of imaging of a tracked object and first position information on a first unmanned mobile apparatus to a second unmanned mobile apparatus. A second transmitter transmits feature information related to an appearance of the tracked object and second position information on the tracked object to the second unmanned mobile apparatus after the first transmitter transmits the transfer request and the first position information. A receiver receives a transfer completion notification from the second unmanned mobile apparatus after the second transmitter transmits the feature information and the second position information.

Abstract: A transmission unit transmits a signal to a relay station. A reception unit receives a signal from the relay station if the transmission unit does not transmit a signal. A control unit determines whether to (1) perform continuous transmission by the transmission unit or (2) perform communication in which transmission by the transmission unit and reception by the reception unit are alternately switched, based on the positional information acquired in the positional information acquisition unit and the communication area information acquired in the communication area information acquisition unit.

Abstract: A mobile wireless terminal includes a receiver and a controller. The receiver receives communication information including transmission information and destination position information which shows a position of a destination from a base station. The controller is configured to perform control to delay increasingly notification starting time at which the transmission information is started to be provided as a distance between the position indicated by the destination position information received by the receiver and a position of a local station is longer.

Abstract: A transmission unit transmits a signal to a relay station. A reception unit receives a signal from the relay station if the transmission unit does not transmit a signal. A control unit determines whether to (1) perform continuous transmission by the transmission unit or (2) perform communication in which transmission by the transmission unit and reception by the reception unit are alternately switched, based on the positional information acquired in the positional information acquisition unit and the communication area information acquired in the communication area information acquisition unit.

Abstract: A container 10 for a catheter simulator comprising an accommodating unit 10a for accommodating a liquid, the accommodating unit 10a being defined by side walls 11 to 14 and a bottom face 15. On the side walls, there are formed connection units 11a and 11c capable of retaining any one of the heart models selected from a four-chamber heart model, a coronary artery model, and a TAVI model, the heart model being installed in the accommodating unit 10a in a state of having the accommodating unit filled with a liquid; and installation parts 11d, 12a, and 13a for inserting a catheter from the outside of the container into simulated blood vessels of the heart model.

Abstract: The present invention provides a method for measuring the gastric acidity of a mammal using a 13C-labeled carbonate compound. Specifically, the present invention relates to a method for measuring the gastric acidity of a mammal including the following steps: (1) using, as a test sample, expired air of a mammalian subject excreted at any point in time within 30 minutes after oral administration of a predetermined amount of a 13C-labeled carbonate compound, measuring behavior of 13CO2 in the expired air; (2) comparing the behavior of 13CO2 (measured 13CO2 behavior) obtained in step (1) with the behavior of corresponding 13CO2 (reference 13CO2 behavior) that has been obtained beforehand in a control mammal; and (3) determining the gastric acidity of the mammalian subject based on a difference between the reference 13CO2 behavior and the measured 13CO2 behavior obtained above.

Abstract: A determiner determines execution of rerouting. A notifier notifies the execution of rerouting if the determiner determines the execution of rerouting. A searcher executes a rerouting search if the determiner determines the execution of rerouting. A measurer measures the distance by which a navigation device has moved along a guide route, which is a result of the rerouting search by the searcher. In a case in which the determiner determines execution of next rerouting, the notifier notifies the execution of rerouting if the measured distance is longer than a threshold value and does not notify the execution of rerouting if the measured distance is smaller than or equal to the threshold value.

Abstract: A method for measuring energy malnutrition in a liver disease test subject, a method for determining whether a liver disease test subject is in an energy malnutrition state, a method for determining the necessity of nutrition therapy for a liver disease test subject having energy malnutrition, a composition usable in these methods, and the like are provided. The method for measuring energy malnutrition in a liver disease test subject includes the steps of collecting expired air containing labeled carbon dioxide that is generated in the body of a liver disease test subject by being converted from a composition containing, as an active ingredient, glucose labeled with at least one isotope C; and determining the ratio of labeled CO2 amount to unlabeled CO2 amount, or the ratio of labeled CO2 amount to total CO2 amount in expired air.

Abstract: A catheter simulator (10) of the invention has a container (20) filled with a liquid; an elastic heart model (30) installed in a floating state in the liquid with which the container (20) is filled; and a pump (50) connected to the heart model (30). The pump (50) is connected to an apex section of the heart model and produces a pulsatile flow from the apex section toward an aorta. Coronary arteries (33) provided on the surface of a main body (30A) of the heart model (30), pulsate together with the main body as a result of the pulsatile flow flowing from the pump (50).

Abstract: A pulsatile flow generating pump for a catheter simulator, which makes it possible to conveniently perform catheter operation training is provided. The pump (10) includes a cylinder (13) provided inside with a piston performing a reciprocating motion; a driving motor (15) causing the piston to perform a reciprocating motion; a link mechanism (19) converting the rotational motion of the driving motor (15) to the reciprocating motion of the piston; an extrusion port (86b), through which a liquid inside the cylinder is extruded to the outside by the piston; a suction port (86a), through which a liquid from the outside is sucked into the cylinder; and a control unit 70 for controlling the rotation of the driving motor 15. The control unit 70 controls the driving motor 15 so as to output pulsatile flows at a rate of 20 times to 200 times per minute.

Abstract: A mobile wireless terminal includes a receiver and a controller. The receiver receives communication information including transmission information and destination position information which shows a position of a destination from a base station. The controller is configured to perform control to delay increasingly notification starting time at which the transmission information is started to be provided as a distance between the position indicated by the destination position information received by the receiver and a position of a local station is longer.

Abstract: This invention provides a method for measuring insulin resistance of a test subject, and a composition suitably used for the method. A method for measuring insulin resistance of a test act comprising steps (a) and (b) below, the method using a composition for measuring insulin resistance comprising, as an active ingredient, a C12-38 fatty acid labeled with at least one isotope of C, wherein the C12-38 fatty acid is converted in the body into labeled carbon dioxide that is excreted in expired air, (a) intravenously administering the composition to a test subject and collecting expired air; and (b) determining the ratio of labeled CO2 amount to unlabeled CO2 amount contained in the expired air or the ratio of labeled CO2 amount to total CO2 amount contained in the expired air.

Abstract: A second terminal apparatus, which is used in substitution for a first terminal apparatus that creates a group, collects a third terminal apparatus and so forth that are to be participated in the group. A first request signal receiver receives from the first terminal apparatus a first request signal by which to request the collection of the third terminal apparatus and so forth participated in the group. A second request signal transmitter transmits a second request signal by which to request the third terminal apparatus and so forth to participate in the group, when the first request signal receiver has received the first request signal.

Abstract: This invention provides a method for measuring glucose metabolism ability of a subject and a composition that is suitably used in the method. The method for measuring glucose metabolism ability of the present invention is as follows: a method for measuring glucose metabolism ability of a subject, using a composition for measuring glucose metabolism ability, the composition comprising, as an active ingredient, glucose labeled with at least one isotope of C, wherein the glucose is converted in the body into labeled carbon dioxide that is excreted in expired air, the method comprising steps (a) and (b) below: (a) administering the composition to the subject and collecting expired air; and (b) determining the ratio of labeled CO2 amount to unlabeled CO2 amount or the ratio of labeled CO2 amount to total CO2 amount.

Abstract: The present invention provides a method of producing an organ model comprising; an outer-shape body forming step in which an outer-shape body 120 having regions 16, 17 to be a hollow portion and a structural wall of the organ model respectively is formed by irradiating curing light and cure the photocurable mold resin 12 and support resin 13 supporting the mold resin based on photographed data of a human organ, a mold shell forming step in which a mold shell 10 having outer and inner shell portions 12A, 12B covering outer and inner surfaces of the organ model respectively is formed by removing the support resin 13 from the outer-shape body 120, a filling step in which a space 15 between the outer and inner shell portions 12A, 12B is filled with a flexible injection molding material 20, and a removing step for removing the mold shell 10.

Abstract: The present invention provides a method for measuring the gastric acidity of a mammal using a 13C-labeled carbonate compound. Specifically, the present invention relates to a method for measuring the gastric acidity of a mammal including the following steps: (1) using, as a test sample, expired air of a mammalian subject excreted at any point in time within 30 minutes after oral administration of a predetermined amount of a 13C-labeled carbonate compound, measuring behavior of 13CO2 in the expired air; (2) comparing the behavior of 13CO2 (measured 13CO2 behavior) obtained in step (1) with the behavior of corresponding 13CO2 (reference 13CO2 behavior) that has been obtained beforehand in a control mammal; and (3) determining the gastric acidity of the mammalian subject based on a difference between the reference 13CO2 behavior and the measured 13CO2 behavior obtained above.

Abstract: The present invention provides a composition for measuring the gastric-emptying function and a method for measuring the gastric-emptying function effectively usable in diagnosing dyspepsia. The present invention also provides a dyspepsia diagnostic agent, a method for diagnosing dyspepsia, and a method for measuring the treatment effect on a patient suffering from gastrointestinal disorders caused by insufficiencies in the gastric-emptying function (including a pharmacotherapy). One of the main features of the composition for measuring the gastric-emptying function of the present invention is that a pyrimidine compound, which is converted to a labeled CO2 gas in the body and excreted in expired air, labeled with an isotope of C or O, is used as an active ingredient. The method of the present invention can be conducted by orally administering the composition to a subject, and measuring the amount or behavior of the labeled CO2 excreted in expired air.

Abstract: The present invention provide a method for measuring and assessing the capacity in an individual subject to metabolize a variety of fluorouracil drugs, such as 5-fluorouracil, which are degraded in the pyrimidine metabolic pathway, and a preparation useful for the measurement and assessment. The present invention can be carried out by: administering a preparation for determining pyrimidine metabolic capacity comprising as an active ingredient a pyrimidine compound or pyrimidine metabolic compound that acts as a substrate for a pyrimidine metabolizing enzyme, in which at least one of the carbon, oxygen, and nitrogen atoms is labeled with an isotope; and assessing in vivo pyrimidine metabolic capacity based on the behavior of an excreted metabolite.

Abstract: Preparations whereby reduction or acceleration of the gastric emptying rate can be noninvasively evaluated: and a method of evaluating the gastric emptying rate by using these preparations. Thus, reduction or acceleration of the gastric emptying rate can be safely and conveniently examined. Namely, theses preparations are useful in objectively diagnosing the gastric motor function, as well as in evaluating and judging the drug effect or therapeutic effect of a drug concerning the gastric motor function on individual patients.

Abstract: Preparations whereby reduction or acceleration of the gastric emptying rate can be noninvasively evaluated: and a method of evaluating the gastric emptying rate by using these preparations. Thus, reduction or acceleration of the gastric emptying rate can be safely and conveniently examined. Namely, theses preparations are useful in objectively diagnosing the gastric motor function, as well as in evaluating and judging the drug effect or therapeutic effect of a drug concerning the gastric motor function on individual patients.